Johns Hopkins Rheumatology

Home / RheumTV / Biologic Medications and Cancer Risk

Biologic Medications and Cancer Risk

By

There has been some speculation on whether or not biologic medications can increase a patient’s risk of getting cancer in the long run. Dr. Laura Cappelli from the Arthritis Center discusses these risks as well as the research studies behind them.

Johns Hopkins Rheumatology

The Division of Rheumatology is a thriving clinical and academic center, which concentrates clinically on providing the most outstanding care to patients affected by a variety of common and uncommon rheumatic disorders.